Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.

Dominic Stephen KingRaoul C ReulenTom ThomasJoht Singh ChandanRasiah ThayakaranAnuradhaa SubramanianKrishna GokhaleNeeraj BhalaKrishnarajah NirantharakumarNicola J AdderleyNigel Trudgill

Published in: Alimentary pharmacology & therapeutics (2020)

The UK prevalence of inflammatory bowel disease is greater than previous reports suggest and we predict an 11% increase in prevalence by the year 2025. Mortality risk in inflammatory bowel disease and colorectal cancer risk in ulcerative colitis are increased compared to matched controls.

Keyphrases

ulcerative colitis
risk factors
cross sectional
emergency department
type diabetes
adipose tissue
adverse drug
skeletal muscle
insulin resistance
glycemic control
weight loss